$0.004800
00.00%
At close: Sep 10, 4:24 PM EDT
$0.004800
00.00%
After Hours: Sep 10, 4:24 PM EDT
15 minutes delayed
Comments
Loading...
Acura Pharmaceuticals (OTC:ACUR) Stock, Earnings Estimates, EPS, And Revenue
Acura Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Feb 28
EPS
$0.000
Quarterly Revenue
$1.3M
Annual Revenue
(as of Dec 31)
(as of Dec 31)
$1.6M
Analyze the earnings history of Acura Pharmaceuticals using advanced sorting and filters.
Data brought to you by Benzinga APIs
Acura Pharmaceuticals (ACUR) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
Acura Pharmaceuticals (ACUR) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Dec 2019 | 2020-02-10 | $46.00K | $92.00K | -50.0 % |
| Sep 2019 | 2019-10-01 | $67.00K | $92.00K | -27.2 % |
FAQ
When is Acura Pharmaceuticals (OTCEM:ACUR) reporting earnings?
Acura Pharmaceuticals ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on February 28, 2020 for Q3.
What were the latest earnings per share (EPS) for Acura Pharmaceuticals (OTCEM:ACUR)?
Acura Pharmaceuticals ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on February 28, 2020 for Q3 and the Actual EPS was $0.00, which hit the estimate of $0.00.
What were Acura Pharmaceuticals’s (OTCEM:ACUR) revenues?
Acura Pharmaceuticals ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on February 28, 2020 for Q3 and the Actual EPS was {{actualEPS}}, which beat the estimate of {{estEPS}}.
Browse earnings estimates, EPS, and revenue on all stocks.